Skip to content

IMPRA® ePTFE Vascular Grafts CF40A74CRecalls & reported problems

Bard Peripheral Vascular, Inc. · IMPRA® ePTFE Vascular Graft, Carboflo® Short Tapered Centerflex™ Carbon-Lined, 7-4 mm x 40 cm · Class 2 · Implant

All models of IMPRA ePTFE Vascular Grafts (52)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741021015), received between Nov 30, 2021 and Nov 30, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Patient Device Interaction Problem1

Patient problems

  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 30, 2021Patient Device Interaction Problem; Patient Device Interaction Problem

    IT WAS REPORTED THAT SOME TIME POST GRAFT PLACEMENT, GRANULOMA FORMATION WAS IDENTIFIED ON THE GRAFT SITE. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

    MAUDE report 12889397 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page